These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6981383)

  • 1. Pseudomonas infection, allergy, and cystic fibrosis.
    Pitcher-Wilmott RW; Levinsky RJ; Gordon I; Turner MW; Matthew DJ
    Arch Dis Child; 1982 Aug; 57(8):582-6. PubMed ID: 6981383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa.
    Wilmott RW; Tyson SL; Matthew DJ
    Am J Dis Child; 1985 Jul; 139(7):669-71. PubMed ID: 4014087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis.
    Reece E; Segurado R; Jackson A; McClean S; Renwick J; Greally P
    BMC Pulm Med; 2017 Apr; 17(1):70. PubMed ID: 28431569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
    Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
    JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The variability of skin test hypersensitivity reactions in cystic fibrosis and asthma.
    Warner JO
    Clin Allergy; 1977 Jul; 7(4):385-9. PubMed ID: 589773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
    De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
    J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of allergic bronchopulmonary aspergillosis in cystic fibrosis in an area with a high frequency of atopy.
    Skov M; McKay K; Koch C; Cooper PJ
    Respir Med; 2005 Jul; 99(7):887-93. PubMed ID: 15939251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ; Soares Magalhães RJ; Paynter S; Bell SC;
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    Arch Dis Child; 1986 Nov; 61(11):1114-20. PubMed ID: 3098186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
    Ratjen F; Döring G; Nikolaizik WH
    Lancet; 2001 Sep; 358(9286):983-4. PubMed ID: 11583754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
    Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
    Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
    Pedersen SS
    APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
    Wainwright CE; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Tiddens HA;
    JAMA; 2011 Jul; 306(2):163-71. PubMed ID: 21750293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
    Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
    PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM; Waugh J; Noble S
    Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between chronic colonization or infection with Pseudomonas aeruginosa and bronchial hyperreactivity in patients with cystic fibrosis].
    Valverde-Molina J; Sánchez-Solís M; Pastor-Vivero MD; García-Marcos L
    Arch Bronconeumol; 2008 Apr; 44(4):180-4. PubMed ID: 18423178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of inflammatory response, infection, and pulmonary function in cystic fibrosis.
    Pereira LC; Moreira EA; Bennemann GD; Moreno YM; Buss Zda S; Barbosa E; Ludwig-Neto N; Wilhelm Filho D; Fröde TS
    Life Sci; 2014 Jul; 109(1):30-6. PubMed ID: 24931908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.